AiRA · Aspira intelligent research assistant
AI aimed at the specific hours Phase 1 operations lose.
AiRA is proprietary technology we are building in-house. It is not a diagnostic, it does not make clinical decisions, and it does not replace investigator judgment. It removes operational drag.
What AiRA does
Four modules, each tied to a measurable operational bottleneck.
We build only where we can point to the hours saved and the reviewer who signed off. Capabilities are labeled honestly by maturity.
Module 01
Cohort intelligence
Structured and unstructured referral information organized against protocol criteria, so coordinators spend their time on likely-eligible candidates rather than chart triage.
Module 02
Phase 1 scheduling engine
Dosing windows, PK draw sequences, staff availability and unit capacity solved together — the constraint problem that quietly sets Phase 1 timelines.
Module 03
Data quality assistance
Pattern checks across source documentation surface likely queries before monitoring visits. Every flag is reviewed by a human before any action.
Module 04
Operational assurance
Audit-traceable logs of every model-assisted suggestion, who reviewed it and what decision followed.
Target outcomes
What we are engineering toward — stated as targets, not claims.
These are internal design goals for AiRA-assisted Phase 1 workflows, measured against our own historical baselines. We publish results when studies close, not before.
Pre-screening hours per enrolled participant
38%
Scheduling conflicts per dosing cohort
45%
Queries open at monitoring visit
52%
Indexed to Aspira's pre-AiRA internal baseline at 100%. Targets under active validation; not sponsor-facing performance guarantees.
Guardrails
What AiRA will never be.
AiRA in development
Built to compress operational lag — not to replace clinical judgment.
AiRA is an internal operations layer under active development. Every output remains subject to investigator and coordinator review, and no clinical decision is automated.
Next step
Want to pilot a protocol with AiRA-assisted operations?
We are selecting a limited number of Phase 1 studies for early AiRA-supported delivery in Ponce.